Crossmark

Real-world outcomes of different treatment strategies in patients with diabetes and three-vessel coronary disease: a mean follow-up 6.3 years study from China

Crossref DOI link: https://doi.org/10.1186/s12933-020-01193-3

Published Online: 2021-01-11

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Xueyan

Xu, Lianjun

Jiang, Lin

Tian, Jian

Zhang, Yin

Wang, Dong

Sun, Kai

Xu, Bo

Zhao, Wei

Hui, Rutai

Gao, Runlin

Song, Lei

Yuan, Jinqing
Funding

Funding for this research was provided by:

The National Key Research and Development Program of China (2016YFC1301300, 2016YFC1301301)

Beijing Natural Science Foundation (7181008)

CAMS Innovation Fund for Medical Sciences (2016-I2M-1-002)

Young and middle-aged talents in the XPCC Science and Technology Project (2020CB012)
License Information

Text and Data Mining valid from 2021-01-11

Version of Record valid from 2021-01-11
More Information

Article History

Received: 20 September 2020

Accepted: 9 December 2020

First Online: 11 January 2021

Ethics approval and consent to participate

: The study was conducted in accordance with the Declaration of Helsinki and was approved by the local ethics committee of the Fuwai hospital’s Research Ethics Committee. The Institutional Review Board approved the study protocol and all of the patients provided written informed consent.

: the manuscript was approved by all authors for publication.

: All authors state that they have no competing interests.

Document is current

Any future updates will be listed below